The Vicos Photographs of John Collier Jr. and Mary E.T. Collier

A selection of pages is presented from an unpublished book layout of photographs made by John Collier Jr. and Mary E.T. Collier in Peru during the 1950s, with a brief introduction and afterword by Malcolm Collier.     

Localization of an Ataxia-Telangiectasia Gene to an −500-kb Interval on Chromosome 11q23.1: Linkage Analysis of 176 Families by an International Consortium

We describe a 20-point linkage analysis map of chromosome 11q22-23 that is based on genotyping 249 families (59 CEPH and 190 A-T). Monte Carlo linkage analyses of 176 ataxia-telangiectasia (A-T) families localizes the major A-T locus to the region between S1819(A4) and S1818(A2). When seven nonlinking families were excluded from subsequent analyses, a 2-lod support interval of ~500 kb was identified between S1819(A4) and S1294. No recombinants were observed between A-T and markers S384, B7, S535, or S1294. Only 17 of the international consortium families have been assigned to complementation groups. The available evidence favors either a cluster of A-T genes on chromosome 11 or intragenic defects in a single gene.     

Metabolism of C19- and C20-gibberellins by cell-free preparations from immature Phaseolus coccineus seed

Gibberellin biosynthesis pathways were investigated using isotopically-labelled C₁₉- and C₂₀-gibberellins and cell-free preparations from immature seed of Phaseous coccineus cv. Prizewinner. The initial steps in an early 13-hydroxylation pathway involved the conversion gibberellin A₁₂-aldehyde (GA₁₂-aldehyde) to GA₁₂ which was 13-hydroxylated to yield GA₅₃, Metabolism of GA₅₃ yielded GA₄₄. In contrast to other cell-free systems, GA₄₄ was not further converted, either as a δ-lactone or an open-lactone structure, to the C-20 aldehyde GA₁₉. GA₁₉ was, however, metabolised to GA₂₀, GA₅ and GA₁. GA₂₀ represented a branch point in the pathway as it was converted both to GA₁, which was an end product, and GA₅ which was further converted to GA₆. Like GA₁, GA₆ was also an end-product of the early 13-hydroxylation pathway.
A non-13-hydroxylation pathway involving GA₄, GA₁₅, GA₂₄ GA₃₇ and GA₃₆ also originated from GA₁₂. The terminal product of this pathway was the 3β-hydroxy C₁₉-gibberellin, GA₄.     

Impaired Postural Control in Healthy Men at Moderate Altitude (1630 M and 2590 M): Data from a Randomized Trial

ObjectivesIntact postural control is essential for safe performance of mountain sports, operation of machinery at altitude, and for piloting airplanes. We tested whether exposure to hypobaric hypoxia at moderate altitude impairs the static postural control of healthy subjects.MethodsIn 51 healthy men, median age 24 y (quartiles 20;28), static control was evaluated on a balance platform in Zurich, 490 m, and during a 4-day sojourn in Swiss mountain villages at 1630 m and 2590 m, 2 days each. The order of altitude exposure was randomized. Total center of pressure path length (COPL) and sway amplitude measured in two directions by a balance platform, and pulse oximetry were recorded. Data were compared between altitudes.ResultsMedian (quartiles) COPL during standing on both legs with eyes open at 490 m and in the evenings on the first and second days at 1630 and 2590 m, respectively were: 50 (45;57), 55 (48;62), 56 (49;61), 53 (47;59), 54 (48;60) cm, P<0.001 ANOVA. Corresponding arterial oxygen saturation was 97% (96;97), 95% (94;96), 95%(94;96), 92%(90;93), 93%(91;93), P<0.001. Anterior-posterior sway amplitudes were larger at 1630 and 2590 m compared to 490 m, P<0.001. Multiple logistic regression analysis confirmed that higher altitudes (1630 and 2590m) were independently associated with increased COPL when controlled for the order of altitude exposure and age (P=0.001).ConclusionsExposure to 1630 and 2590m was associated with impaired static postural control even when visual references were available.

Trial Registration

ClinicalTrials.gov {"type":"clinical-trial","attrs":{"text":"NCT01130948","term_id":"NCT01130948"}}NCT01130948.     

Synthesis of analogs of (1,4)-3- and 5-imino oxazepane, thiazepane, and diazepane as inhibitors of nitric oxide synthases

A series of 3- and 5-imino analogs from oxazepane, thiazepane, and diazepane was prepared and evaluated as inhibitors of human nitric oxide synthesis (NOS). The most potent iNOS inhibitor was the thiazepane analog 25 (IC(50) = 0.19 microM).     

How plant life‐history and ecological traits relate to species rarity and commonness at varying spatial scales

Comparative studies investigating relationships between plant traits and species rarity and commonness were surveyed to establish whether global patterns have emerged that would be of practical use in management strategies aimed at the long‐term conservation of species. Across 54 studies, 94 traits have been examined in relation to abundance, distribution and threatened status at local, regional and geographical spatial scales. Most traits (63) have yet to be the focus of more than one study. Half of the studies involved less than 10 species, and one‐quarter did not replicate rare–common contrasts. Although these features of the literature make it difficult to demonstrate robust generalizations regarding trait relationships with species rarity, some important findings surfaced in relation to traits that have been examined in two or more studies. Species with narrow geographical distributions were found to produce significantly fewer seeds (per unit measurement) than common species (in four of six studies), but did not differ with respect to breeding system (five of five studies). The majority of traits (including seed size, competitive ability, growth form and dispersal mode) were related to rarity in different ways from one study to the next. The highly context‐dependent nature of most trait relationships with rarity implies that application of knowledge concerning rare–common differences and similarities to management plans will vary substantially for different vegetation types and on different continents. A comparative analysis of distribution patterns in relation to several life‐history and ecological traits among 700 Australian eucalypt species was then performed. A significantly dispro­portionate number of tall species and species with long flowering durations had wide geographical ranges. Trait relationships with distribution were explored further through the development of a methodology incorporating multiple spatial scales. Eight theoretical categories were described illustrating variation in distribution patterns (and hence rarity and commonness) across small, intermediate and large spatial scales, based on the spatial structure of species occurrence across the Australian landscape. Each eucalypt species was placed into a category, and trait variation was explored across all species in relation to distribution patterns across multiple spatial scales. This approach yielded important information about trait relationships with distribution among the eucalypts, linking the spatial structure of points‐of‐occurrence with patterns of rarity and commonness. With the pressing need to protect increasing numbers of threatened species and slow rates of extinction, the development and refinement of a broadly usable methodology for rarity studies that encompasses multiple spatial scales, which can be used for any geographical location, will be useful in both conservation and management.     

Acute effects of thoracic irradiation on lung function and structure in awake sheep

To investigate the acute physiological and structural changes after lung irradiation, the effects of whole-lung irradiation were investigated in fourteen sheep. Ten sheep were prepared with vascular and chronic lung lymph catheters, then a week later were given 1,500 rad whole-lung radiation and monitored for 2 days. Four sheep were given the same dose of radiation and were killed 4 h later for structural studies. Lung lymph flow increased at 3 h after radiation (14.6 +/- 2.1 ml/h) to twice the base-line flow rate (7.5 +/- 1.3), with a high lymph-to-plasma protein concentration. Pulmonary arterial pressure increased twofold from base line (18 +/- 1.6 cmH2O) at 2 h after radiation (33 +/- 3.8). Cardiac output and systemic pressure in the aorta did not change after lung radiation. Arterial O2 tension decreased from 85 +/- 3 to 59 +/- 4 Torr at 1 day after radiation. Lymphocyte counts in both blood and lung lymph decreased to a nadir by 4 h and remained low. Thromboxane B2 concentration in lung lymph increased from base line (0.07 +/- 0.03 ng/ml) to peak at 3 h after radiation (8.2 +/- 3.7 ng/ml). The structural studies showed numerous damaged lymphocytes in the peripheral lung and bronchial associated lymphoid tissue. Quantitative analysis of the number of granulocytes in peripheral lung showed no significant change (base line 6.2 +/- 0.8 granulocytes/100 alveoli, 4 h = 10.3 +/- 2.3). The most striking change involved lung airways. The epithelial lining of the majority of airways from intrapulmonary bronchus to respiratory bronchiolus revealed damage with the appearance of intracellular and intercellular cell fragments and granules. This new large animal model of acute radiation lung injury can be used to monitor physiological, biochemical, and morphological changes after lung radiation. It is relevant to the investigation of diffuse oxidant lung injury as well as to radiobiology per se.     

High throughput screens yield small molecule inhibitors of Leishmania CRK3:CYC6 cyclin-dependent kinase

Background

Leishmania species are parasitic protozoa that have a tightly controlled cell cycle, regulated by cyclin-dependent kinases (CDKs). Cdc2-related kinase 3 (CRK3), an essential CDK in Leishmania and functional orthologue of human CDK1, can form an active protein kinase complex with Leishmania cyclins CYCA and CYC6. Here we describe the identification and synthesis of specific small molecule inhibitors of bacterially expressed Leishmania CRK3:CYC6 using a high throughput screening assay and iterative chemistry. We also describe the biological activity of the molecules against Leishmania parasites.

Methodology/Principal Findings

In order to obtain an active Leishmania CRK3:CYC6 protein kinase complex, we developed a co-expression and co-purification system for Leishmania CRK3 and CYC6 proteins. This active enzyme was used in a high throughput screening (HTS) platform, utilising an IMAP fluorescence polarisation assay. We carried out two chemical library screens and identified specific inhibitors of CRK3:CYC6 that were inactive against the human cyclin-dependent kinase CDK2:CycA. Subsequently, the best inhibitors were tested against 11 other mammalian protein kinases. Twelve of the most potent hits had an azapurine core with structure activity relationship (SAR) analysis identifying the functional groups on the 2 and 9 positions as essential for CRK3:CYC6 inhibition and specificity against CDK2:CycA. Iterative chemistry allowed synthesis of a number of azapurine derivatives with one, compound 17, demonstrating anti-parasitic activity against both promastigote and amastigote forms of L. major. Following the second HTS, 11 compounds with a thiazole core (active towards CRK3:CYC6 and inactive against CDK2:CycA) were tested. Ten of these hits demonstrated anti-parasitic activity against promastigote L. major.

Conclusions/Significance

The pharmacophores identified from the high throughput screens, and the derivatives synthesised, selectively target the parasite enzyme and represent compounds for future hit-to-lead synthesis programs to develop therapeutics against Leishmania species. Challenges remain in identifying specific CDK inhibitors with both target selectivity and potency against the parasite.